{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:59:41Z","timestamp":1790755181421,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T00:00:00Z","timestamp":1443744000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00109-015-1344-5","type":"journal-article","created":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T22:29:20Z","timestamp":1443738560000},"page":"235-245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Connectivity mapping uncovers small molecules that modulate neurodegeneration in Huntington\u2019s disease models"],"prefix":"10.1007","volume":"94","author":[{"given":"Joshua L.","family":"Smalley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Breda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurdeep","family":"Kooner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Luthi-Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Gant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaviano","family":"Giorgini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,2]]},"reference":[{"issue":"6","key":"1344_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72(6):971\u2013983","journal-title":"Cell"},{"issue":"1","key":"1344_CR2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10(1):83\u201398","journal-title":"Lancet Neurol"},{"issue":"3","key":"1344_CR3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S (2001) Loss of normal huntingtin function: new developments in Huntington\u2019s disease research. Trends Neurosci 24(3):182\u2013188","journal-title":"Trends Neurosci"},{"issue":"5222","key":"1344_CR4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, Ge P, Vonsattel JP, Gusella JF, Joyner AL et al (1995) Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 269(5222):407\u2013410","journal-title":"Science"},{"issue":"7113","key":"1344_CR5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443(7113):787\u2013795","journal-title":"Nature"},{"issue":"43","key":"1344_CR6","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","volume":"27","author":"AD Strand","year":"2007","unstructured":"Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C, Beal MF, Jones L, Kooperberg C, Olson JM et al (2007) Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27(43):11758\u201311768","journal-title":"J Neurosci"},{"key":"1344_CR7","author":"MD Sepers","year":"2014","unstructured":"Sepers MD, Raymond LA (2014) Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease. Drug Discov Today. doi: 10.1016\/j.drudis.2014.02.006","journal-title":"Drug Discov Today"},{"issue":"5334","key":"1344_CR8","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277(5334):1990\u20131993","journal-title":"Science"},{"issue":"13","key":"1344_CR9","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/11.13.1505","volume":"11","author":"Y Kouroku","year":"2002","unstructured":"Kouroku Y, Fujita E, Jimbo A, Kikuchi T, Yamagata T, Momoi MY, Kominami E, Kuida K, Sakamaki K, Yonehara S et al (2002) Polyglutamine aggregates stimulate ER stress signals and caspase-12 activation. Hum Mol Genet 11(13):1505\u20131515","journal-title":"Hum Mol Genet"},{"issue":"7010","key":"1344_CR10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431(7010):805\u2013810","journal-title":"Nature"},{"issue":"19","key":"1344_CR11","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1074\/jbc.M111.252577","volume":"287","author":"LG Nucifora","year":"2012","unstructured":"Nucifora LG, Burke KA, Feng X, Arbez N, Zhu S, Miller J, Yang G, Ratovitski T, Delannoy M, Muchowski PJ et al (2012) Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein. J Biol Chem 287(19):16017\u201316028","journal-title":"J Biol Chem"},{"issue":"7","key":"1344_CR12","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, Reddy PH (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum Mol Genet 20(7):1438\u20131455","journal-title":"Hum Mol Genet"},{"issue":"5512","key":"1344_CR13","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL et al (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291(5512):2423\u20132428","journal-title":"Science"},{"issue":"20","key":"1344_CR14","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","volume":"96","author":"A Kazantsev","year":"1999","unstructured":"Kazantsev A, Preisinger E, Dranovsky A, Goldgaber D, Housman D (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci U S A 96(20):11404\u201311409","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1344_CR15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","volume":"22","author":"SH Li","year":"2002","unstructured":"Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 22(5):1277\u20131287","journal-title":"Mol Cell Biol"},{"issue":"12","key":"1344_CR16","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97(12):6763\u20136768","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1344_CR17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D et al (2006) Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet 15(6):965\u2013977","journal-title":"Hum Mol Genet"},{"issue":"15","key":"1344_CR18","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","volume":"16","author":"A Kuhn","year":"2007","unstructured":"Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, Kooperberg C, Becanovic K, Pouladi MA, Sathasivam K, Cha JH et al (2007) Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16(15):1845\u20131861","journal-title":"Hum Mol Genet"},{"issue":"17","key":"1344_CR19","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","volume":"11","author":"R Luthi-Carter","year":"2002","unstructured":"Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, Peters NL, Woods AM, Chan EY, Kooperberg C, Krainc D et al (2002) Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 11(17):1911\u20131926","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1344_CR20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddi443","volume":"15","author":"BL Apostol","year":"2006","unstructured":"Apostol BL, Illes K, Pallos J, Bodai L, Wu J, Strand A, Schweitzer ES, Olson JM, Kazantsev A, Marsh JL et al (2006) Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1\/2 protects against mutant huntingtin-associated toxicity. Hum Mol Genet 15(2):273\u2013285","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1344_CR21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.02.102","volume":"1088","author":"SF Crocker","year":"2006","unstructured":"Crocker SF, Costain WJ, Robertson HA (2006) DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6\/2) reveals neuroinflammation and insulin associations. Brain Res 1088(1):176\u2013186","journal-title":"Brain Res"},{"issue":"6","key":"1344_CR22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4161\/auto.4898","volume":"3","author":"RA Floto","year":"2007","unstructured":"Floto RA, Sarkar S, Perlstein EO, Kampmann B, Schreiber SL, Rubinsztein DC (2007) Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy 3(6):620\u2013622","journal-title":"Autophagy"},{"issue":"3","key":"1344_CR23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","volume":"16","author":"CT Aiken","year":"2004","unstructured":"Aiken CT, Tobin AJ, Schweitzer ES (2004) A cell-based screen for drugs to treat Huntington's disease. Neurobiol Dis 16(3):546\u2013555","journal-title":"Neurobiol Dis"},{"issue":"11","key":"1344_CR24","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1073\/pnas.0511256103","volume":"103","author":"RA Bodner","year":"2006","unstructured":"Bodner RA, Outeiro TF, Altmann S, Maxwell MM, Cho SH, Hyman BT, McLean PJ, Young AB, Housman DE, Kazantsev AG (2006) Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proc Natl Acad Sci U S A 103(11):4246\u20134251","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 4","key":"1344_CR25","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.1073\/pnas.182426599","volume":"99","author":"V Heiser","year":"2002","unstructured":"Heiser V, Engemann S, Brocker W, Dunkel I, Boeddrich A, Waelter S, Nordhoff E, Lurz R, Schugardt N, Rautenberg S et al (2002) Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay. Proc Natl Acad Sci U S A 99(Suppl 4):16400\u201316406","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"1344_CR26","doi-asserted-by":"crossref","first-page":"15149","DOI":"10.1073\/pnas.211566398","volume":"98","author":"S Ramaswamy","year":"2001","unstructured":"Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP et al (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98(26):15149\u201315154","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1344_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0092-8674(00)00015-5","volume":"102","author":"TR Hughes","year":"2000","unstructured":"Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, Bennett HA, Coffey E, Dai H, He YD et al (2000) Functional discovery via a compendium of expression profiles. Cell 102(1):109\u2013126","journal-title":"Cell"},{"issue":"3","key":"1344_CR28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cell.2006.06.040","volume":"126","author":"AB Parsons","year":"2006","unstructured":"Parsons AB, Lopez A, Givoni IE, Williams DE, Gray CA, Porter J, Chua G, Sopko R, Brost RL, Ho CH et al (2006) Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126(3):611\u2013625","journal-title":"Cell"},{"issue":"5795","key":"1344_CR29","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN et al (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795):1929\u20131935","journal-title":"Science"},{"issue":"6","key":"1344_CR30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.cmet.2011.03.020","volume":"13","author":"SD Kunkel","year":"2011","unstructured":"Kunkel SD, Suneja M, Ebert SM, Bongers KS, Fox DK, Malmberg SE, Alipour F, Shields RK, Adams CM (2011) mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab 13(6):627\u2013638","journal-title":"Cell Metab"},{"key":"1344_CR31","author":"RP Mason","year":"2013","unstructured":"Mason RP, Casu M, Butler N, Breda C, Campesan S, Clapp J, Green EW, Dhulkhed D, Kyriacou CP, Giorgini F (2013) Glutathione peroxidase activity is neuroprotective in models of Huntington's disease. Nat Genet. doi: 10.1038\/ng.2732","journal-title":"Nat Genet"},{"issue":"6","key":"1344_CR32","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam K, Neueder A, Gipson TA, Landles C, Benjamin AC, Bondulich MK, Smith DL, Faull RL, Roos RA, Howland D et al (2013) Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A 110(6):2366\u20132370","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1344_CR33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44(6):559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"1344_CR34","first-page":"1313","volume":"37","author":"JK Elenbaas","year":"1980","unstructured":"Elenbaas JK (1980) Centrally acting oral skeletal muscle relaxants. Am J Hosp Pharm 37(10):1313\u20131323","journal-title":"Am J Hosp Pharm"},{"issue":"8726","key":"1344_CR35","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0140-6736(90)92962-H","volume":"336","author":"NF Olivieri","year":"1990","unstructured":"Olivieri NF, Koren G, Hermann C, Bentur Y, Chung D, Klein J, St Louis P, Freedman MH, McClelland RA, Templeton DM (1990) Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients. Lancet 336(8726):1275\u20131279","journal-title":"Lancet"},{"issue":"6857","key":"1344_CR36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald MK et al (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413(6857):739\u2013743","journal-title":"Nature"},{"issue":"11","key":"1344_CR37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","volume":"21","author":"S Campesan","year":"2011","unstructured":"Campesan S, Green EW, Breda C, Sathyasaikumar KV, Muchowski PJ, Schwarcz R, Kyriacou CP, Giorgini F (2011) The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease. Curr Biol 21(11):961\u2013966","journal-title":"Curr Biol"},{"issue":"6","key":"1344_CR38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","volume":"50","author":"RH Myers","year":"1991","unstructured":"Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA, Richardson EP Jr, Bird ED (1991) Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 50(6):729\u2013742","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"1344_CR39","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 19(7):2522\u20132534","journal-title":"J Neurosci"},{"issue":"15","key":"1344_CR40","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/hmg\/dds178","volume":"21","author":"RK Chaturvedi","year":"2012","unstructured":"Chaturvedi RK, Hennessey T, Johri A, Tiwari SK, Mishra D, Agarwal S, Kim YS, Beal MF (2012) Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease. Hum Mol Genet 21(15):3474\u20133488","journal-title":"Hum Mol Genet"},{"issue":"142","key":"1344_CR41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003799","volume":"4","author":"T Tsunemi","year":"2012","unstructured":"Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RAV, Lazarowski ER, Damian VA, Masliah E, La Spada AR (2012) PGC-1 alpha Rescues Huntington's Disease Proteotoxicity by Preventing Oxidative Stress and Promoting TFEB Function. Sci Transl Med 4(142), 142ra97. doi: 10.1126\/scitranslmed.3003799","journal-title":"Sci Transl Med"},{"key":"1344_CR42","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/bi00900a030","volume":"3","author":"HA Lardy","year":"1964","unstructured":"Lardy HA, Connelly JL, Johnson D (1964) Antibiotic studies. Ii. Inhibition of phosphoryl transfer in mitochondria by oligomycin and aurovertin. Biochemistry 3:1961\u20131968","journal-title":"Biochemistry"},{"issue":"36","key":"1344_CR43","doi-asserted-by":"crossref","first-page":"14525","DOI":"10.1073\/pnas.0704482104","volume":"104","author":"H Varma","year":"2007","unstructured":"Varma H, Cheng R, Voisine C, Hart AC, Stockwell BR (2007) Inhibitors of metabolism rescue cell death in Huntington's disease models. Proc Natl Acad Sci U S A 104(36):14525\u201314530","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5\u20136","key":"1344_CR44","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/BF01966788","volume":"15","author":"R Kramar","year":"1984","unstructured":"Kramar R, Hohenegger M, Srour AN, Khanakah G (1984) Oligomycin toxicity in intact rats. Agents Actions 15(5\u20136):660\u2013663","journal-title":"Agents Actions"},{"issue":"1","key":"1344_CR45","first-page":"205","volume":"15","author":"LA Videla","year":"1987","unstructured":"Videla LA, Villena MI, Salgado C, Canales P, Lissi EA (1987) Antioxidant capacity of desferrioxamine in biological systems. Biochem Int 15(1):205\u2013214","journal-title":"Biochem Int"},{"issue":"6","key":"1344_CR46","first-page":"428","volume":"8","author":"KV Mann","year":"1989","unstructured":"Mann KV, Picciotti MA, Spevack TA, Durbin DR (1989) Management of acute iron overdose. Clin Pharm 8(6):428\u2013440","journal-title":"Clin Pharm"},{"issue":"7","key":"1344_CR47","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archinte.1985.00360070091015","volume":"145","author":"AI Schafer","year":"1985","unstructured":"Schafer AI, Rabinowe S, Le Boff MS, Bridges K, Cheron RG, Dluhy R (1985) Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload. Arch Intern Med 145(7):1217\u20131221","journal-title":"Arch Intern Med"},{"issue":"2","key":"1344_CR48","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.CCM.0000199069.19193.89","volume":"34","author":"C Ritter","year":"2006","unstructured":"Ritter C, da Cunha AA, Echer IC, Andrades M, Reinke A, Lucchiari N, Rocha J, Streck EL, Menna-Barreto S, Moreira JCF et al (2006) Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med 34(2):471\u2013477","journal-title":"Crit Care Med"},{"issue":"3","key":"1344_CR49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/phrs.2000.0769","volume":"43","author":"SY Saad","year":"2001","unstructured":"Saad SY, Najjar TA, Al-Rikabi AC (2001) The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 43(3):211\u2013218","journal-title":"Pharmacol Res"},{"issue":"7","key":"1344_CR50","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.freeradbiomed.2011.06.027","volume":"51","author":"TT Reed","year":"2011","unstructured":"Reed TT (2011) Lipid peroxidation and neurodegenerative disease. Free Radic Biol Med 51(7):1302\u20131319","journal-title":"Free Radic Biol Med"},{"issue":"23","key":"1344_CR51","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1111\/j.1742-4658.2006.05537.x","volume":"273","author":"WJ Firdaus","year":"2006","unstructured":"Firdaus WJ, Wyttenbach A, Giuliano P, Kretz-Remy C, Currie RW, Arrigo AP (2006) Huntingtin inclusion bodies are iron-dependent centers of oxidative events. FEBS J 273(23):5428\u20135441","journal-title":"FEBS J"},{"issue":"1","key":"1344_CR52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0006-8993(02)03730-7","volume":"959","author":"YC Liu","year":"2003","unstructured":"Liu YC, Lo YK, Wu SN (2003) Stimulatory effects of chlorzoxazone, a centrally acting muscle relaxant, on large conductance calcium-activated potassium channels in pituitary GH3 cells. Brain Res 959(1):86\u201397","journal-title":"Brain Res"},{"issue":"3","key":"1344_CR53","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0022-3565(24)38803-2","volume":"296","author":"Y Cao","year":"2001","unstructured":"Cao Y, Dreixler JC, Roizen JD, Roberts MT, Houamed KM (2001) Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds. J Pharmacol Exp Ther 296(3):683\u2013689","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"1344_CR54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/15376516.2010.546815","volume":"21","author":"X Gao","year":"2011","unstructured":"Gao X, Yang X, Zhang B (2011) Neuroprotection of taurine against bilirubin-induced elevation of apoptosis and intracellular free calcium ion in vivo. Toxicol Mech Methods 21(5):383\u2013387","journal-title":"Toxicol Mech Methods"},{"issue":"10","key":"1344_CR55","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1016\/j.bmc.2009.03.065","volume":"17","author":"AZ Abdel-Azeem","year":"2009","unstructured":"Abdel-Azeem AZ, Abdel-Hafez AA, El-Karamany GS, Farag HH (2009) Chlorzoxazone esters of some non-steroidal anti-inflammatory (NSAI) carboxylic acids as mutual prodrugs: design, synthesis, pharmacological investigations and docking studies. Bioorg Med Chem 17(10):3665\u20133670","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"1344_CR56","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/d852525a-e5bc-452b-ae57-5dc2c39fed68","volume":"8","author":"D Young","year":"2013","unstructured":"Young D, Mayer F, Vidotto N, Schweizer T, Berth R, Abramowski D, Shimshek DR, van der Putten PH, Schmid P (2013) Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice. PLoS One 8(9), e75108. doi: 10.1371\/journal.pone.0075108","journal-title":"PLoS One"},{"issue":"10","key":"1344_CR57","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.0500055102","volume":"102","author":"N Agrawal","year":"2005","unstructured":"Agrawal N, Pallos J, Slepko N, Apostol BL, Bodai L, Chang LW, Chiang AS, Thompson LM, Marsh JL (2005) Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. Proc Natl Acad Sci U S A 102(10):3777\u20133781","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-015-1344-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-015-1344-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-015-1344-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T18:05:30Z","timestamp":1748628330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-015-1344-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1007\/s00109-015-1344-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725835213.793510305","asserted-by":"object"}]},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,2]]}}}